THE EFFECT OF CMV INFECTION ON PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE IN A COHORT OF HEMOPHILIC MEN FOLLOWED FOR UP TO 13 YEARS FROM SEROCONVERSION

被引:62
作者
SABIN, CA
PHILLIPS, AN
LEE, CA
JANOSSY, G
EMERY, V
GRIFFITHS, PD
机构
[1] ROYAL FREE HOSP, SCH MED, CTR HAEMOPHILIA, LONDON NW3 2PF, ENGLAND
[2] ROYAL FREE HOSP, SCH MED, DEPT HAEMATOL, LONDON NW3 2PF, ENGLAND
[3] ROYAL FREE HOSP, SCH MED, DEPT CLIN IMMUNOL, LONDON NW3 2PF, ENGLAND
[4] ROYAL FREE HOSP, SCH MED, DEPT VIROL, LONDON NW3 2PF, ENGLAND
关键词
D O I
10.1017/S095026880005799X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The effect of prior infection with cytomegalovirus (CMV) on progression of HIV disease in a cohort of 111 men with haemophilia was studied after 13 years followup. The relative hazards associated with CMV positivity on progression to AIDS, death and a CD4 count of 0.05 x 10(9)/l were 2.28, 2.42 and 2.34, respectively. CMV seropositive patients were significantly older than the seronegative and this was controlled for by using a Cox proportional hazards model. The relative hazards for the three endpoints decreased to 1.89, 1.82 and 1.93 respectively and were marginally non-significant (P = 0.05, 0.08 and 0.08 for the three endpoints respectively). We conclude that this cohort continues to show evidence of a 'co-factor' effect associated with prior infection with CMV which is confounded by age but not completely explained by age differences. The potential biological significance of these results is discussed in the context of recent controlled clinical trials which show a survival benefit from long-term high-dose acyclovir, a drug with activity in vivo against CMV and other herpesviruses.
引用
收藏
页码:361 / 372
页数:12
相关论文
共 36 条
[1]  
Altman, 1991, PRACTICAL STATICTS M
[2]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[4]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[5]   HUMAN IMMUNODEFICIENCY VIRUS-1 DISEASE PROGRESSION IN HEMOPHILIACS [J].
BECHERER, PR ;
SMILEY, ML ;
MATTHEWS, TJ ;
WEINHOLD, KJ ;
MCMILLAN, CW ;
WHITE, GC .
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (03) :204-209
[6]   SEROEPIDEMIOLOGIC STUDIES ON THE ACQUISITION OF ANTIBODIES TO CYTOMEGALO-VIRUS, HERPES-SIMPLEX VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS AMONG GENERAL-HOSPITAL PATIENTS AND THOSE ATTENDING A CLINIC FOR SEXUALLY-TRANSMITTED DISEASES [J].
BERRY, NJ ;
BURNS, DM ;
WANNAMETHEE, G ;
GRUNDY, JE ;
LUI, SF ;
PRENTICE, HG ;
GRIFFITHS, PD .
JOURNAL OF MEDICAL VIROLOGY, 1988, 24 (04) :385-393
[7]   RADIOIMMUNOASSAY FOR THE DETECTION OF IGG ANTIBODIES TO HERPES-SIMPLEX VIRUS AND ITS USE AS A PROGNOSTIC INDICATOR OF HSV EXCRETION IN TRANSPLANT RECIPIENTS [J].
BERRY, NJ ;
GRUNDY, JE ;
GRIFFITHS, PD .
JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (02) :147-154
[8]   AIDS INCUBATION IN 1891 HIV SEROCONVERTERS FROM DIFFERENT EXPOSURE GROUPS [J].
BIGGAR, RJ .
AIDS, 1990, 4 (11) :1059-1066
[9]   THE INFLUENCE OF AGE ON THE LATENCY PERIOD TO AIDS IN PEOPLE INFECTED BY HIV THROUGH BLOOD-TRANSFUSION [J].
BLAXHULT, A ;
GRANATH, F ;
LIDMAN, K ;
GIESECKE, J .
AIDS, 1990, 4 (02) :125-129
[10]  
BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x